Results for tag: "Elotuzumab"

Elotuzumab is a monoclonal antibody used in the treatment of multiple myeloma, a type of cancer that affects the plasma cells in the bone marrow. It is used in combination with other drugs, such as lenalidomide and dexamethasone, to treat patients who have received at least one prior therapy. Elotuzumab works by targeting a protein called SLAMF7, which is found on the surface of multiple myeloma cells. This helps the immune system to recognize and attack the cancer cells. Elotuzumab has been approved by the US Food and Drug Administration (FDA) for use in combination with lenalidomide and dexamethasone for the treatment of multiple myeloma. Elotuzumab is marketed by Bristol-Myers Squibb, Novartis, and Amgen. It is also available in generic form from several generic drug manufacturers. Show Less Read more